Deployment of Aristotle must be soon!No matter which way they go about it to deploy Aristotle, it must be soon in order to get name recognition and prove the effectiveness of the tests to determine what cancer is lurking inside someone's body. Failure to deploy soon it will give more time for a competitor to get to market first and steal the spot light that Aristotle needs so much to seize important market share.
Furthermore, any further delay from the CEO to lauch Aristotle will be interpreted by the market that Aristotle is not all what it's supposed to be. Therefore, it will be very important what the CEO will announce concerning Aristotle in the coming quarter news release.
As for concerns about the covid-19 and the political environment nobody knows with certainty where it's all going in the future. Let's hope that the CEO will not use it as a pretext to throw a cold shower on announcing delays for the Aristotle launch because it will be looked very badly by the market.